OTCQX: RHHBY) announced today positive topline results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity
Some patients genetically predisposed to robust GLP-1 receptor activation may benefit from injecting into their abdomen consistently (where blood flow typically supports faster absorption), while others benefit from thigh injections (associated with slightly slower, steadier absorption)
Even foods labeled as healthy, like granola bars and flavored yogurts, can contain high levels of added sugar
Theyll cover you having your stomach basically amputated, but they wont cover a drug, which, if you dont like it, you just stop
Eating smaller meals and avoiding fatty foods can help reduce these symptoms
Proteins are present throughout our bodies